Cargando…

In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate

The EGCG, an important component of polyphenol in green tea, is well known due to its numerous health benefits. We employed the reverse docking method for the identification of the putative targets of EGCG in the anti-tumor target protein database and these targets were further uploaded to public da...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wang, Xiong, Xiuhong, Li, Xue, Zhang, Qinyang, Yang, Wentao, Du, Linfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480119/
https://www.ncbi.nlm.nih.gov/pubmed/30979098
http://dx.doi.org/10.3390/molecules24071445
_version_ 1783413502820483072
author Wang, Wang
Xiong, Xiuhong
Li, Xue
Zhang, Qinyang
Yang, Wentao
Du, Linfang
author_facet Wang, Wang
Xiong, Xiuhong
Li, Xue
Zhang, Qinyang
Yang, Wentao
Du, Linfang
author_sort Wang, Wang
collection PubMed
description The EGCG, an important component of polyphenol in green tea, is well known due to its numerous health benefits. We employed the reverse docking method for the identification of the putative targets of EGCG in the anti-tumor target protein database and these targets were further uploaded to public databases in order to understand the underlying pharmacological mechanisms and search for novel EGCG-associated targets. Similarly, the pharmacological linkage between tumor-related proteins and EGCG was manually constructed in order to provide greater insight into the molecular mechanisms through a systematic integration with applicable bioinformatics. The results indicated that the anti-tumor mechanisms of EGCG may involve 12 signaling transduction pathways and 33 vital target proteins. Moreover, we also discovered four novel putative target proteins of EGCG, including IKBKB, KRAS, WEE1 and NTRK1, which are significantly related to tumorigenesis. In conclusion, this work may provide a useful perspective that will improve our understanding of the pharmacological mechanism of EGCG and identify novel potential therapeutic targets.
format Online
Article
Text
id pubmed-6480119
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64801192019-04-30 In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate Wang, Wang Xiong, Xiuhong Li, Xue Zhang, Qinyang Yang, Wentao Du, Linfang Molecules Article The EGCG, an important component of polyphenol in green tea, is well known due to its numerous health benefits. We employed the reverse docking method for the identification of the putative targets of EGCG in the anti-tumor target protein database and these targets were further uploaded to public databases in order to understand the underlying pharmacological mechanisms and search for novel EGCG-associated targets. Similarly, the pharmacological linkage between tumor-related proteins and EGCG was manually constructed in order to provide greater insight into the molecular mechanisms through a systematic integration with applicable bioinformatics. The results indicated that the anti-tumor mechanisms of EGCG may involve 12 signaling transduction pathways and 33 vital target proteins. Moreover, we also discovered four novel putative target proteins of EGCG, including IKBKB, KRAS, WEE1 and NTRK1, which are significantly related to tumorigenesis. In conclusion, this work may provide a useful perspective that will improve our understanding of the pharmacological mechanism of EGCG and identify novel potential therapeutic targets. MDPI 2019-04-11 /pmc/articles/PMC6480119/ /pubmed/30979098 http://dx.doi.org/10.3390/molecules24071445 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Wang, Wang
Xiong, Xiuhong
Li, Xue
Zhang, Qinyang
Yang, Wentao
Du, Linfang
In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
title In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
title_full In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
title_fullStr In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
title_full_unstemmed In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
title_short In Silico Investigation of the Anti-Tumor Mechanisms of Epigallocatechin-3-Gallate
title_sort in silico investigation of the anti-tumor mechanisms of epigallocatechin-3-gallate
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6480119/
https://www.ncbi.nlm.nih.gov/pubmed/30979098
http://dx.doi.org/10.3390/molecules24071445
work_keys_str_mv AT wangwang insilicoinvestigationoftheantitumormechanismsofepigallocatechin3gallate
AT xiongxiuhong insilicoinvestigationoftheantitumormechanismsofepigallocatechin3gallate
AT lixue insilicoinvestigationoftheantitumormechanismsofepigallocatechin3gallate
AT zhangqinyang insilicoinvestigationoftheantitumormechanismsofepigallocatechin3gallate
AT yangwentao insilicoinvestigationoftheantitumormechanismsofepigallocatechin3gallate
AT dulinfang insilicoinvestigationoftheantitumormechanismsofepigallocatechin3gallate